| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Promis Neurosciences, Inc. (PMN) has 15 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. PMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.14M | $28.66M | - | |
| 10% | 3.14M | $28.66M | - | |
| CEO | 600.0K | $5.48M | - | |
| 10% | 539.1K | $4.92M | - | |
| 10% | 539.1K | $4.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Kirwin Patrick D. | Director | Buy | 4,000 | $5.92 | $23,680.00 | +10.5% | +2.4% | -68.4% | |
| Jul 11, 2022 | Williams Eugene | Chairman And CEO | Buy | 1,000 | $9.80 | $9,800.00 | +0.6% | -25.6% | -62.8% |